{
    "Trade/Device Name(s)": [
        "CHOLESTEROL",
        "HDL-Cholesterol",
        "LDL-Cholesterol",
        "TRIGLYCERIDES"
    ],
    "Submitter Information": "Medicon Hellas, S.A.",
    "510(k) Number": "K232404",
    "Predicate Device Reference 510(k) Number(s)": [
        "K925603",
        "K981224",
        "K981303",
        "K063804"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "CHH",
        "LBS",
        "MRR",
        "CDT"
    ],
    "Summary Letter Date": "July 9, 2024",
    "Summary Letter Received Date": "July 10, 2024",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1175",
        "21 CFR 862.1475",
        "21 CFR 862.1705"
    ],
    "Regulation Name(s)": [
        "Cholesterol (Total) Test System",
        "HDL-Cholesterol Test System",
        "LDL-Cholesterol Test System",
        "Triglycerides Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cholesterol",
        "HDL-Cholesterol",
        "LDL-Cholesterol",
        "Triglycerides"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Diatron Pictus 500 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic colorimetric assay",
        "Accelerator Selective Detergent method",
        "Selective Detergent method",
        "Glycerol-3-phosphate-peroxidase (GPO-POD) method",
        "Photometry"
    ],
    "Methodologies": [
        "Enzymatic colorimetric measurement",
        "Accelerator selective detergent separation",
        "Selective detergent separation"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Medicon Hellas cholesterol, HDL, LDL, and triglycerides reagent kits for quantitative determination in human serum on Diatron Pictus 500 Analyzer",
    "Indications for Use Summary": "Quantitative determination of cholesterol, HDL-cholesterol, LDL-cholesterol, and triglycerides in human serum for diagnosing and treating lipid and lipoprotein metabolism disorders, diabetes mellitus, atherosclerosis, liver and renal diseases, and various endocrine disorders",
    "fda_folder": "Clinical Chemistry"
}